Published by Align Wellness
Blood sugar, weight, GLP-1 medications and the metabolic markers that predict long-term health.
AnalysisWeight Medicine
The FDA approved an oral version of Wegovy in December 2025 and Lilly's orforglipron in April 2026. One pill has strict morning rules. The other does not. Neither is quite as strong as the leading injections.
AnalysisThe Off-Ramp
Semaglutide and tirzepatide produce weight loss that once required surgery. The trial data on stopping them is just as important, and it should shape how people plan to use them.
AnalysisBy the Numbers
A Tufts analysis of national data found that only 6.8 percent of US adults had optimal levels across five basic markers. Most people can learn where they stand with a tape measure and a routine blood draw.
AnalysisOcean State Field Notes
ExplainerFitness Is Fate
GuideNarragansett Bay
AnalysisLabel Change
